5-FU

You have access
8-Chloroadenosine Induces ER Stress and Apoptotic Cell Death in Cholangiocarcinoma Cells
JOMNARONG LERTSUWAN, JISNUSON SVASTI and JUTAMAAD SATAYAVIVAD

Anticancer Research December 2023, 43 (12) 5425-5436; DOI: https://doi.org/10.21873/anticanres.16746
You have access
E2F7/RAD51AP1 Axis Inhibits Endometrial Cancer Sensitivity to 5-FU via the Fatty Acid Metabolic Pathway
XIAOYAN HUANG, ZAIXIN WU, CHUNHONG XIAO and XI CHEN

Anticancer Research November 2023, 43 (11) 4905-4914; DOI: https://doi.org/10.21873/anticanres.16688
Open Access
Recombinant Oral Methioninase (o-rMETase) Combined With Oxaliplatinum Plus 5-Fluorouracil Improves Survival of Mice With Massive Colon-Cancer Peritoneal Carcinomatosis
MIN JEONG KIM, QINGHONG HAN, MICHAEL BOUVET, ROBERT M. HOFFMAN and JUN HO PARK

Anticancer Research January 2023, 43 (1) 19-24; DOI: https://doi.org/10.21873/anticanres.16129
You have access
The INCH Trial – Induction Chemotherapy in Patients With Bulky Anal Canal Cancer: Evaluation of the Pilot Phase
FRANCESCA DE FELICE, ALESSIA FALLARINO, FRANCO IAFRATE, VERONICA MAIURI, GIOVANNI GALLONI, GIOVANNI TURRIZIANI COLONNA, RAFFAELLA DE PIETRO, GIUSEPPINA CHIARELLO, CLAUDIA MARCHETTI, NADIA BULZONETTI, DANIELA MUSIO and VINCENZO TOMBOLINI

Anticancer Research June 2021, 41 (6) 3187-3191; DOI: https://doi.org/10.21873/anticanres.15105
You have access
Cell Cycle Dysregulation Is Associated With 5-Fluorouracil Resistance in Gastric Cancer Cells
DA SOM KIM, KYOUNGMI MIN and SUK KYEONG LEE

Anticancer Research June 2020, 40 (6) 3247-3254; DOI: https://doi.org/10.21873/anticanres.14306
You have access
Clinical Significance of Jagged-1 Activated by APEX1 as a Chemoresistance Factor in Advanced Gastric Cancer
HONG-BEUM KIM, HEE-JEONG LEE, GEE-BEUM KIM, HYUN-JONG LIM, JUN HEE PARK and SANG-GON PARK

Anticancer Research April 2020, 40 (4) 1897-1904; DOI: https://doi.org/10.21873/anticanres.14144
You have access
In Vitro Study of the Anti-cancer Effect of Alternate-day 5-Fluorouracil in Head and Neck Cancer Cells
YORIHISA MORO, YASUNAO KOGASHIWA, HIROYUKI SAKURAI, RYO TAKAHASHI, TORU KIMURA, MASATAKA HIRASAKI, YOSHIFUMI MATSUMOTO, MASASHI SUGASAWA and NAOYUKI KOHNO

Anticancer Research November 2019, 39 (11) 6041-6047; DOI: https://doi.org/10.21873/anticanres.13810
You have access
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
MATTHEW R. KEARNEY, EMERSON Y. CHEN, GINA M. VACCARO, JOHN STROTHER, ANDREA BURT, KENDRA TODD, JEFF DONOVAN, KERSTIN M. KAMPA-SCHITTENHELM and CHARLES D. LOPEZ

Anticancer Research January 2019, 39 (1) 245-252; DOI: https://doi.org/10.21873/anticanres.13104
You have access
Evaluation of the Antitumor Potential of the Resorcinolic Lipid 3-Heptyl-3,4,6-trimethoxy-3H-isobenzofuran-1-one in Breast Cancer Cells
ANA PAULA MALUF RABACOW, ALISSON MEZA, EDWIN JOSÉ TORRES DE OLIVEIRA, NATAN DE DAVID, NEIMAR VITOR, ANDRÉIA CONCEIÇÃO MILAN BROCHADO ANTONIOLLI-SILVA, MARIA DE FÁTIMA CEPA MATOS, RENATA TRENTIM PERDOMO, ROBERTO DA SILVA GOMES, DÊNIS PIRES DE LIMA, ADILSON BEATRIZ and RODRIGO JULIANO OLIVEIRA

Anticancer Research August 2018, 38 (8) 4565-4576; DOI: https://doi.org/10.21873/anticanres.12761
You have access
In Vitro Chemosensitivity Test for Gastric Cancer Specimens Predicts Effectiveness of Oxaliplatin and 5-Fluorouracil
YOSHIKAZU KANAZAWA, TAKESHI YAMADA, ITSUO FUJITA, DAISUKE KAKINUMA, KUNIHIKO MATSUNO, HIROKI ARAI, TOMOHIRO SHIMODA, KAZUHIDE KO, SHUNJI KATO, TAKESHI MATSUTANI, NOBUTOSHI HAGIWARA, TSUTOMU NOMURA and EIJI UCHIDA

Anticancer Research November 2017, 37 (11) 6401-6405;

Main menu

User menu

Search

5-FU

Pages